Also known as hematopoietic, erythropoietin drug is defined as a glycoprotein hormone that controls erythropoiesis. Erythropoiesis is defined as the production of red blood cells (RBC). A new report on the global erythropoietin drug market, published by Market Research Future (MRFR), estimates that this market can visualize expansion at 9.5% CAGR between 2017 and 2023. The most significant market driving factor for the global Erythropoietin Drug Market is the increasing prevalence of diseases like cancer and various renal diseases. The increasing investment in medical research & development (R…
